Nuclear medicine imaging has aroused
great interest in the design
and synthesis of versatile radioactive nanoprobes, while most of the
methods developed for radiolabeling nanoprobes are difficult to satisfy
the criteria of clinical translation, including easy operation, mild
labeling conditions, high efficiency, and high radiolabeling stability.
Herein, we demonstrated the universality of a simple but efficient
radiolabeling method recently developed for constructing nuclear imaging
nanoprobes, that is, ligand anchoring group-mediated radiolabeling
(LAGMERAL). In this method, a diphosphonate-polyethylene glycol (DP-PEG)
decorating on the surface of inorganic nanoparticles plays an essential
role. In principle, owing to the strong binding affinity to a great
variety of metal ions, it can not only endow the underlying nanoparticles
containing metal ions including some main group metal ions, transition
metal ions, and lanthanide metal ions with excellent colloidal stability
and biocompatibility but also enable efficient radiolabeling through
the diphosphonate group. Based on this assumption, inorganic nanoparticles
such as Fe3O4 nanoparticles, NaGdF4:Yb,Tm nanoparticles, and Cu2–x
S nanoparticles, as representatives of functional inorganic nanoparticles
suitable for different imaging modalities including magnetic resonance
imaging (MRI), upconversion luminescence imaging (UCL), and photoacoustic
imaging (PAI), respectively, were chosen to be radiolabeled with different
kinds of radionuclides such as SPECT nuclides (e.g., 99mTc), PET nuclides (e.g., 68Ga), and therapeutic SPECT
nuclides (e.g., 177Lu) to demonstrate the reliability of
the LAGMERAL approach. The experimental results showed that the obtained
nanoprobes exhibited high radiolabeling stability, and the whole radiolabeling
process had negligible impacts on the physical and chemical properties
of the initial nanoparticles. Through passive targeting SPECT/MRI
of glioma tumor, active targeting SPECT/UCL of colorectal cancer,
and SPECT/PAI of lymphatic metastasis, the outstanding potentials
of the resulting radioactive nanoprobes for sensitive tumor diagnosis
were demonstrated, manifesting the feasibility and efficiency of LAGMERAL.